Common equity is a zero-recovery trade. The DIP lenders (Oaktree/QIA) hold superpriority priming liens on all assets and control the restructuring process. Monitor the Section 363 sale or plan of reorganization for potential recovery to junior stakeholders, but expect zero for common stock. The move to pink sheets on September 8 will eliminate institutional liquidity. Do not hold through the delisting.
Price Chart
Executive Summary
BioXcel Therapeutics filed for Chapter 11 bankruptcy on August 27, 2026, and this 8-K reports two terminal events: (1) entry into a $77.25M DIP financing facility with Oaktree and Qatar Investment Authority to fund the bankruptcy process, and (2) Nasdaq delisting notice with trading suspension effective September 8, 2026, with the company not appealing. The DIP facility provides $19M in new money and rolls up $58.25M in prepetition debt at 13% interest, maturing January 27, 2027. Common stock will move to the pink sheets, severely reducing liquidity and institutional ownership. Common equity is effectively worthless in the Chapter 11 process given the superpriority priming liens on all assets and the DIP lenders' control of the restructuring.
Key Facts
- Company filed voluntary Chapter 11 petitions on August 27, 2026
- Entered $77.25M DIP Credit Agreement with Oaktree and Qatar Investment Authority on August 31, 2026
- DIP facility includes $19M new money loans (two $9.5M draws) and $58.25M roll-up of prepetition debt
- Loans bear interest at 13.00% per annum with a 4.0% exit fee
- Nasdaq notified company of delisting on August 31, 2026; trading suspended September 8, 2026
- Company will not appeal Nasdaq's delisting determination
- Common stock expected to trade on Pink Limited Market (pink sheets) after delisting
- DIP facility matures January 27, 2027
- DIP lenders have superpriority administrative expense claims and first priority priming liens on substantially all assets
- Minimum liquidity covenant of $250 thousand under DIP facility
Financial Impact
Chapter 11 filing with $77.25M DIP facility at 13% interest; common equity likely extinguished in restructuring. Market cap of $5M implies near-zero recovery for common shareholders.
Risk Factors
- Common stock likely receives no distribution in Chapter 11 given superpriority DIP liens on all assets
- Nasdaq delisting on September 8 eliminates institutional trading and severely reduces liquidity
- DIP facility matures January 27, 2027 — company must exit bankruptcy or sell assets by then
- Pink sheet trading may not materialize or may be extremely thin
- DIP lenders can accelerate and foreclose on all assets upon any event of default
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (BTAI) — Batch item 1 | 0001104659-26-104106 |
| Document: 0001104659-26-104106-index-headers.html | 0001104659-26-104106 |
| Document: 0001104659-26-104106-index.html | 0001104659-26-104106 |
| Document: 0001104659-26-104106.txt | 0001104659-26-104106 |
| 8-K Filing (BTAI) — Batch item 5 | 0001104659-26-104106 |
| Document: 0001104659-26-104106-index-headers.html | 0001104659-26-104106 |
| Document: 0001104659-26-104106-index.html | 0001104659-26-104106 |
| Document: 0001104659-26-104106.txt | 0001104659-26-104106 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 7w ago | 8-K | $0.1370 | awaiting T+60 | — | — |
Aug 28, 2026 8w ago | Press Release | $0.1814 | awaiting T+60 | — | — |
Aug 25, 2026 8w ago | 8-K | $0.7422 | awaiting T+60 | — | — |
Aug 11, 2026 10w ago | 8-K | $0.9320 | awaiting T+60 | — | — |
Aug 3, 2026 12w ago | 8-K | $0.8480 | awaiting T+60 | — | — |
Jul 6, 2026 16w ago | 8-K | $1.10 | awaiting T+60 | — | — |
May 22, 2026 22w ago | Insider Cluster | $1.22 $0.8274 | ▲ +32.18% | ▲ +34.91% | — |
May 20, 2026 22w ago | 144 | $1.14 $0.8900 | ▼ −21.93% | ▼ −26.23% | — |
May 15, 2026 23w ago | 8-K | $1.14 $0.9319 | ▼ −18.25% | ▼ −22.77% | — |
May 15, 2026 23w ago | Press Release | $1.14 $0.9319 | ▲ +18.25% | ▲ +22.77% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers